These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11942740)

  • 1. Intracavernosal injection therapy and surgical therapy in diabetic patients with erectile dysfunction.
    Savoca G; Silvestre G; Belgrano E
    Diabetes Nutr Metab; 2002 Feb; 15(1):53-7. PubMed ID: 11942740
    [No Abstract]   [Full Text] [Related]  

  • 2. Current treatment and future perspectives for erectile dysfunction.
    Hatzichristou DG
    Int J Impot Res; 1998 May; 10 Suppl 1():S3-13. PubMed ID: 9669215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
    Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
    Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
    La Vignera S; Calogero AE; Cannizzaro MA; Condorelli R; Noto Z; Vicari E
    Minerva Endocrinol; 2006 Dec; 31(4):251-61. PubMed ID: 17213792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernosal injection algorithm.
    Albaugh JA
    Urol Nurs; 2006 Dec; 26(6):449-53. PubMed ID: 17253079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavernosal injections and fibrosis: myth or reality?
    Tal R; Mulhall JP
    BJU Int; 2008 Aug; 102(5):525-6. PubMed ID: 18485038
    [No Abstract]   [Full Text] [Related]  

  • 7. Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments.
    Kucuk EV; Tahra A; Bindayi A; Onol FF
    Andrology; 2016 Sep; 4(5):952-6. PubMed ID: 27368423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group B streptococcal septicemia following intracavernous injection therapy for erectile dysfunction in diabetes.
    Nalesnik JG; Jones L; Kraus SR
    J Urol; 2004 Jul; 172(1):151-2. PubMed ID: 15201758
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction.
    El-Sakka AI
    Int J Impot Res; 2006; 18(2):180-5. PubMed ID: 16163370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of erectile dysfunction].
    Loran OB; Sheplev PA; Nesterov SN
    Urol Nefrol (Mosk); 1998; (3):39-46. PubMed ID: 9644990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical therapy in erectile dysfunction].
    Floth A
    Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal injection therapy: a practical guide.
    Mulhall JP
    Tech Urol; 1997; 3(3):129-34. PubMed ID: 9422443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the current role of intracavernosal injection in management of erectile dysfunction?
    El-Sakka AI
    Int J Impot Res; 2016 May; 28(3):88-95. PubMed ID: 27076113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A positive urine opiate screen following intracavernosal papaverine injection.
    Pierpaoli SM; Mulhall JP
    J Urol; 1998 Apr; 159(4):1299. PubMed ID: 9507861
    [No Abstract]   [Full Text] [Related]  

  • 15. [The impact of creating andrology units on the treatment of erectile dysfunction with intracavernosal injections].
    Ramada Benlloch FJ; Navalon Verdejo P; Claramonte Ramon FJ; Beltrán Mesenguer JF; Ramos de Campos M; Zaragozá Orts J
    Arch Esp Urol; 1999 Apr; 52(3):257-61. PubMed ID: 10371742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of local penile therapy.
    Montorsi F; Salonia A; Zanoni M; Pompa P; Cestari A; Guazzoni G; Barbieri L; Rigatti P
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S70-81. PubMed ID: 11850739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overactive corpus cavernosum: a novel cause of erectile dysfunction.
    Shafik A; Shafik I; El-Sibai O; Shafik AA
    Andrologia; 2004 Dec; 36(6):378-83. PubMed ID: 15541054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a needle-free high-pressure injection system with needle-tipped injection of intracavernosal alprostadil for erectile dysfunction.
    Harding LM; Adeniyi A; Everson R; Barker S; Ralph DJ; Baranowski AP
    Int J Impot Res; 2002 Dec; 14(6):498-501. PubMed ID: 12494285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dionysos plaster or gunpowder without bullets].
    Wolf HI
    Ugeskr Laeger; 2008 Apr; 170(16):1375; author reply 1375. PubMed ID: 18441605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.